000 | 01796 a2200469 4500 | ||
---|---|---|---|
005 | 20250516024757.0 | ||
264 | 0 | _c20110719 | |
008 | 201107s 0 0 eng d | ||
022 | _a1096-0945 | ||
024 | 7 |
_a10.1016/j.yexmp.2011.02.006 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aOliva, Joan | |
245 | 0 | 0 |
_aProtective effect of quercetin, EGCG, catechin and betaine against oxidative stress induced by ethanol in vitro. _h[electronic resource] |
260 |
_bExperimental and molecular pathology _cJun 2011 |
||
300 |
_a295-9 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAldehydes _xmetabolism |
650 | 0 | 4 |
_aAnti-Infective Agents, Local _xadverse effects |
650 | 0 | 4 |
_aAntioxidants _xpharmacology |
650 | 0 | 4 |
_aBetaine _xpharmacology |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aCarcinoma, Hepatocellular _xdrug therapy |
650 | 0 | 4 |
_aCatechin _xanalogs & derivatives |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCytochrome P-450 CYP2E1 _xgenetics |
650 | 0 | 4 |
_aEthanol _xadverse effects |
650 | 0 | 4 |
_aGastrointestinal Agents _xpharmacology |
650 | 0 | 4 |
_aHepatocytes _xdrug effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLiver Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aMalondialdehyde _xmetabolism |
650 | 0 | 4 |
_aOxidative Stress _xdrug effects |
650 | 0 | 4 |
_aQuercetin _xpharmacology |
650 | 0 | 4 |
_aRNA, Messenger _xgenetics |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
700 | 1 | _aBardag-Gorce, Fawzia | |
700 | 1 | _aTillman, Brittany | |
700 | 1 | _aFrench, Samuel W | |
773 | 0 |
_tExperimental and molecular pathology _gvol. 90 _gno. 3 _gp. 295-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.yexmp.2011.02.006 _zAvailable from publisher's website |
999 |
_c20627874 _d20627874 |